Latest Insider Transactions at Structure Therapeutics Inc. (GPCR)
This section provides a real-time view of insider transactions for Structure Therapeutics Inc. (GPCR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Structure Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Structure Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2024
|
Ashley Hall Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
67,290
+50.0%
|
-
|
|
Sep 18
2024
|
Crespo Blas Coll Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,600
+46.89%
|
-
|
|
Jun 12
2024
|
Raymond C Stevens CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+8.89%
|
$0
$0.44 P/Share
|
|
Jun 10
2024
|
Raymond C Stevens CHIEF EXECUTIVE OFFICER |
SELL
Conversion of derivative security
|
Direct |
555,000
-46.31%
|
-
|
|
Jun 03
2024
|
Xichen Lin CHIEF SCIENTIFIC OFFICER |
SELL
Conversion of derivative security
|
Direct |
106,200
-55.34%
|
-
|
|
Jun 03
2024
|
Xichen Lin CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
106,200
+35.62%
|
$0
$0.34 P/Share
|
|
Mar 15
2024
|
Xichen Lin CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
85,707
+50.0%
|
-
|
|
Mar 15
2024
|
Mark Allen Bach CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
26,235
+50.0%
|
-
|
|
Mar 15
2024
|
Yingli Ma CHIEF TECHNOLOGY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
36,729
+50.0%
|
-
|
|
Mar 15
2024
|
Jun Yoon CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
59,469
+5.03%
|
-
|
|
Mar 15
2024
|
Raymond C Stevens CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
134,682
+10.1%
|
-
|
|
May 10
2023
|
Bvf Partners L P > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
7,410,518
-100.0%
|
-
|
|
Feb 07
2023
|
Daniel G Welch |
BUY
Conversion of derivative security
|
Indirect |
123,508
+50.0%
|
-
|
|
Feb 07
2023
|
Ramy Farid Director |
BUY
Conversion of derivative security
|
Indirect |
642,245
+16.46%
|
-
|
|
Feb 07
2023
|
Fmr LLC |
BUY
Conversion of derivative security
|
Indirect |
5,816,554
+22.73%
|
-
|
|
Feb 07
2023
|
Fil LTD |
BUY
Conversion of derivative security
|
Indirect |
6,473,761
+26.89%
|
-
|